Celldex Therapeutics, Inc (CLDX) Stock Price

33.78 ▲ +0.80 (+2.43%)
Open: 32.94 Vol: 1.05M Day's range: 32.625 - 34.13 Jun 24, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CLDX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 33.75▲ 33.74▲ 33.65▲ 33.11▲ 31.51▲
MA10 33.65▲ 33.56▲ 33.46▲ 32.06▲ 31.92▲
MA20 33.76▲ 33.49▲ 33.30▲ 31.04▲ 30.66▲
MA50 33.59▲ 33.17▲ 32.70▲ 32.05▲ 27.36▲
MA100 33.45▲ 32.55▲ 31.12▲ 30.24▲ 26.51▲
MA200 33.35▲ 30.99▲ 30.98▲ 28.16▲ 31.19▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ 0.015▲ -0.003▼ 0.463▲ -0.070▼
RSI 54.865▲ 56.464▲ 59.212▲ 62.837▲ 60.091▲
STOCH 62.701     65.241     61.346     85.505▲ 41.752    
WILL %R -26.667     -31.602     -31.602     -6.087▲ -27.126    
CCI 38.615     81.870     97.767     98.320     73.206    
Latest Filters Detected On CLDX
CDL $CLDX Doji Candlestick Pattern Detected Set Alert
Celldex Therapeutics, Inc News
Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and ...
Sunday, June 14, 2026 07:29 AM
Treatment with barzolvolimab resulted in rapid, significant, and durable improvements in angioedema in patients with moderate to severe CSUSeven months after the completion of dosing (Week 76), up to ...
Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
Sunday, June 14, 2026 02:23 AM
CDX-622 is a novel, bispecific antibody combining mast cell depletion and TSLP inhibition, two independent pathways contributing to multiple I&I diseasesCDX-622 targets the soluble form of stem cell ...
Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress
Wednesday, June 10, 2026 02:54 PM
Flash talks on barzolvolimab clinical program in CSU and Cold Urticaria ---- Late-breaking poster presentation on CDX-622 -- HAMPTON, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) ...
CLDX historical stock data
date open high low close volume
24/06/26 32.94 34.13 32.625 33.78 1,050,550
23/06/26 32.87 33.7225 32.57 32.98 634,870
22/06/26 32.90 33.46 32.26 33.41 1,922,222
18/06/26 33.69 34.095 32.35 32.43 1,832,270
17/06/26 32.58 33.555 32.2901 32.93 974,399
16/06/26 31.71 32.44 31.41 32.32 960,980
15/06/26 31.29 32.21 31.05 32.12 977,521
12/06/26 30.15 31.41 29.94 31.27 599,519
11/06/26 29.41 30.21 29.33 29.96 734,015
10/06/26 29.92 30.345 29.285 29.35 443,591
Quote Details
52wk Low:19.52
52wk High:35.79
Vol:1.05M
Avg Vol(3m):17.3M
1Y Chng:+47.45%
1M Chng:+5.56%
Add to Watch List
More Information
Index US Composite
Market Cap. 2.59B